Objective: Retrievable inferior vena cava (IVC) filters are intended for short-term placement, and serious complications have been reported in patients with chronic IVC filters. As a result, national health agencies have encouraged each hospital to assess all retrievable IVC filters for filter removal. The aim of our study was to identify patients with unretrieved chronic IVC filters to document complications and removal techniques.
Objective: Retrievable inferior vena cava (IVC) filters are intended for short-term placement, and serious complications have been reported in patients with chronic IVC filters. As a result, national health agencies have encouraged each hospital to assess all retrievable IVC filters for filter removal. The aim of our study was to identify patients with unretrieved chronic IVC filters to document complications and removal techniques.
Methods: Using the data set from a previously performed retrospective review of all IVC filter procedures performed between January 2001 and December 2013, we identified a cohort with unretrieved IVC filters. These patients were invited by registered mail for clinic review with computed tomography imaging to determine complications and to offer removal if indicated. Data collected included demographics, venous thromboembolism risk factors, medical comorbidities, complications, and retrieval characteristics.
Results: During the study period, 1123 IVC filter procedures were performed; 69% (n ¼ 810) were insertions and 31% (n ¼ 313) were retrievals. Of the 663 retrievable filters, successful removal rate was 41.6% (n ¼ 276); 22 patients had a failed retrieval attempt. After the exclusion of filters removed subsequent to the data collection period, 289 patients were identified to still have a filter in situ. There were 193 patients confirmed internally or by Ministry of Health as deceased; 89 patients were notified, with no current contact information available for the remaining 7 patients. There were 34 patients who attended for review, 19 female and 15 male, with an average age of 63.5 years. Complications documented at computed tomography were two occluded IVCs (5.8%), four fractured filters (11.7%), and filter penetration in all cases (38% grade 2, 53% grade 3). Fifteen patients decided to proceed with filter removal, 10 refused the opportunity, and 5 were unfit or had an ongoing indication for the filter. Two are awaiting removal and two had IVC occlusion. Retrieval was successful in 93% of cases (14/15). The mean time to removal from implantation was 3846.9 days (standard deviation, 980.3 days). Advanced techniques were employed in nine cases, and there were no deaths or morbidities.
Conclusions: Retrievable IVC filters are not benign, and mounting evidence suggests their complication rate may be higher than previously recognized, the incidence of which increases over time. Chronic unretrieved filters can be removed safely using standard and advanced techniques with low morbidity and mortality.
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Are Demographics Affecting Vascular Surgery Volumes? A Province-Wide Perspective
Jim Dooner, MD. Island Health, Victoria, BC, Canada
Objective: The purpose of this study was to evaluate the relationship between population increase, changing age demographics, and the throughput of vascular procedures province-wide from 1993 to 2016.
Methods: Population data and age-related distribution were obtained from the Government of BC database. Billing codes were used to quantify the number of procedures across the spectrum of vascular surgery from 1993 until 2016 from the BC Medical Services Commission and Doctors of BC. Annual procedure rates as well as the type of practitioner performing the procedures were tracked.
Results: During the study period , the total population grew by 34%, whereas the population segments older than 60 years grew by 90% provincially. Consultations increased by 40% between 2001 and 2016, but despite the advancing age, there was no significant growth in the number of abdominal aortic aneurysms repaired by all methods. There was a dramatic reduction in aortoiliac reconstruction and a stable pattern of lower extremity bypass procedures. Amputation volumes have not grown significantly during the study period, and carotid endarterectomy has been stable. Vascular access procedures have increased by >400%, and the number of venous cases completed more than doubled during the period of study.
Conclusions: Despite significant growth in the segment of the population older than 60 years, there appears to be little growth in the throughput of vascular surgery across a broad spectrum of procedures. Despite growth in demand for vascular consultation, there has been no increase in the operations performed, with notable exceptions. A substantial increase has occurred in vascular access procedures and venous surgery. Both can be performed as ambulatory procedures. One is left to speculate about the lack of growth in procedural volumes, but the limited access to inpatient beds would be one factor, whereas lack of access to primary care and transportation issues may also have a significant impact.
Author Disclosures: J. Dooner: Nothing to disclose. Objective: Admission to the hospital provides an ideal opportunity to ensure that appropriate morbidity-and mortality-improving medications are prescribed. Antiplatelet (AP) medications (eg, aspirin, clopidogrel) and 3-hydroxy-3-methylglutaryl-coenzyme A reductase inhibitors (statins; eg, rosuvastatin) have class 1A evidence for patients with peripheral arterial disease. Similarly, perioperative AP medications and statins reduce mortality after vascular surgery. Our objective was to establish a fivecomponent discharge improvement program that results in all eligible patients' having a statin and AP medication prescribed at discharge.
Improving Critical Discharge Medication
Methods: We used the Evidence-based Practice for Improving Quality model to create a comprehensive and systematic discharge protocol to improve both statin and AP therapy adherence at a Canadian center. Our multidisciplinary team within the Division of Vascular Surgery collaborated to identify five key components/steps in the discharge process. Our intervention was initiated on July 24, 2017, for patients admitted to the Grey Nuns Hospital in Edmonton, Canada, under the Division of Vascular Surgery. Prospective data have been collected and maintained within our regional Vascular Quality Initiative (VQI) chapter with outcome results reviewed every month. To date, we have evaluated 6 months before and 6 months after our intervention.
Results: There were 485 eligible patients added to our local VQI database (January 1, 2017-December 31, 2017). Before our intervention, 73.3% of patients were appropriately discharged with both AP and statin medications. After our intervention, the average medication adherence on discharge increased to 84.4%. Of the remaining patients who did not have indicated medications at the time of discharge, 17% were missing an AP agent and 7.5% were missing a statin.
Conclusions: Overall, this VQI initiative improved key steps in discharging patients from our centralized vascular surgery center. We improved medication adherence for morbidity-and mortality-improving AP and statin therapies. With this intervention, our medication adherence is higher than both regional and national averages.
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